Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging-Reference-Cited by-同舟云学术

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging

Published:2000-08 Issue:2 Volume:56 Page:255-260
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Catalona William J,Southwick Paula C,Slawin Kevin M,Partin Alan W,Brawer Michael K,Flanigan Robert C,Patel Anup,Richie Jerome P,Walsh Patrick C,Scardino Peter T,Lange Paul H,Gasior Gail H,Loveland Kathleen G,Bray Kurtis R

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer;Catalona;J Urol,1994

2. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values;Keetch;J Urol,1994

3. Serum prostate-specific antigen in a community-based population of healthy men;Oesterling;JAMA,1993

4. PSA density (PSAD);Seaman;Urol Clin North Am,1993

5. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening;Catalona;JAMA,1995

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06

2. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS);Journal of Urology;2023-10

3. Application of MXene for precise cancer diagnosis and treatment;CHINESE J INORG CHEM;2023

4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer;Asian Journal of Urology;2023-04

5. Metastatic bone damage in prostate cancer as a cause of chronic musculoskeletal pain;Clinical Medicine and Pharmacology;2023-02-01